Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Internal Medicine | Oncology | Pathology | Psychiatry | Journal

Back to Journal Articles

Depression May Affect Survival in Metastatic Renal Cancer

Last Updated: August 03, 2012.

 

Depressive symptoms linked to dysregulation of cortisol and expression of pro-inflammatory genes

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
For patients with metastatic renal cell carcinoma, depressive symptoms may be a predictor of survival, with potential links to cortisol dysregulation and expression of pro-inflammatory and pro-metastatic genes, according to a study published online Aug. 1 in PLoS One.

FRIDAY, Aug. 3 (HealthDay News) -- For patients with metastatic renal cell carcinoma (RCC), depressive symptoms may be a predictor of survival, with potential links to cortisol dysregulation and expression of pro-inflammatory and pro-metastatic genes, according to a study published online Aug. 1 in PLoS One.

Lorenzo Cohen, Ph.D., from the University of Texas MD Anderson Cancer Center in Houston, and colleagues examined the clinical effects of psychosocial factors and cortisol dysregulation and associated transcription control pathways in 217 patients with metastatic RCC. Psychological factors were assessed by self-completed questionnaires. To identify potential alterations in circadian rhythms and genomic pathways, cortisol levels and whole genome transcription profiles were assessed.

After controlling for disease risk category the researchers found that the Centers for Epidemiologic Studies-Depression (CES-D) scores and cortisol slope correlated with decreased survival (hazard ratio, 1.5 [95 percent confidence interval, 1.00 to 2.23; P = 0.05] and 1.9 [P = 0.002], respectively). In a complete model, only cortisol slope and risk category remained significant. In functional genomic analyses, depressive symptoms were linked to increased expression of pro-inflammatory and pro-metastatic genes in circulating leukocytes. In patients with high CES-D, 116 transcripts were upregulated and 57 transcripts were downregulated by an average of at least 50 percent. In a subset of patients, these changes were also found in the tumor.

"Our findings, and those of others, suggest that mental health and social well-being can affect biological processes, which influence cancer-related outcomes," Cohen said in a statement. "They also suggest that screening for mental health should be part of standard care because there are well accepted ways of helping people manage distress, even in the face of a life-threatening illness."

Abstract
Full Text

Copyright © 2012 HealthDay. All rights reserved.


Previous: Spray-Based Therapy Promising for Chronic Venous Leg Ulcers Next: Almost Half of U.S. Adults Have at Least One CVD Risk Factor

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2013
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.